Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy

被引:1
|
作者
Alyamani, Mohammad [1 ]
Michael, Patrick [1 ,2 ]
Hettel, Daniel [1 ,2 ]
Thomas, Lewis [1 ,2 ]
Lundy, Scott D. [2 ]
Berk, Mike [1 ]
Patel, Mona [1 ]
Li, Jianbo [3 ]
Rashidi, Hooman [4 ]
McKenney, Jesse K. [4 ]
Klein, Eric A. [1 ,2 ]
Sharifi, Nima [1 ,2 ,5 ,6 ]
机构
[1] Lerner Res Inst, Genitourinary Malignancies Res Ctr, Cleveland, OH USA
[2] Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH USA
[3] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA
[4] Cleveland Clin, Pathol & Lab Med Inst, Dept Pathol, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH USA
[6] Univ Miami, Miller Sch Med, Desai Sethi Urol Inst, Rosenstiel Med Sci Bldg,1600 NW 10th Ave,Room 602, Miami, FL 33136 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2023年 / 133卷 / 17期
关键词
SERUM; 17-HYDROXYPROGESTERONE; THERAPY; HYPOGONADISM; VARICOCELE; TISSUE; MEN;
D O I
10.1172/JCI171117
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND. Generally, clinical assessment of gonadal testosterone (T) in human physiology is determined using concentrations measured in peripheral blood. Prostatic T exposure is similarly thought to be determined from peripheral T exposure. Despite the fact that androgens drive prostate cancer, peripheral T has had no role in the clinical evaluation or treatment of men with localized prostate cancer.METHODS. To assess the role of local androgen delivery in prostate cancer, we obtained blood from the (periprostatic) prostatic dorsal venous complex in 266 men undergoing radical prostatectomy from July 2014 to August 2021 and compared dorsal T (DT) levels with those in circulating peripheral blood (PT) and prostatic tissue. Comprehensive targeted steroid analysis and unbiased metabolomics analyses were performed. The association between the DT/PT ratio and progression-free survival after prostatectomy was assessed.RESULTS. Surprisingly, in some men, DT levels were enriched several-fold compared with PT levels. For example, 20% of men had local T concentrations that were at least 2-fold higher than peripheral T concentrations. Isocaproic acid, a byproduct of androgen biosynthesis, and 17-OH-progesterone, a marker of intratesticular T, were also enriched in the dorsal vein of these men, consistent with testicular shunting. Men with enriched DT had higher rates of prostate cancer recurrence. DT/PT concentration ratios predicted worse outcomes even when accounting for known clinical predictors.CONCLUSIONS. These data suggest that a large proportion of men have a previously unappreciated exposure to an undiluted and highly concentrated T supply. Elevated periprostatic T exposure was associated with worse clinical outcomes after radical prostatectomy. FUNDING. National Cancer Institute (NCI), NIH grants R01CA172382, R01CA236780, R01CA261995, R01CA249279, and R50CA251961; US Army Medical Research and Development Command grants W81XWH2010137 and W81XWH-22-1-0082.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] ELEVATED PERIPROSTATIC VENOUS TESTOSTERONE CORRELATES WITH PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
    Duifee, Michael Patrick
    Mohammad, Alyamani
    Daniel, Hettel
    Lewis, Thomas
    Scott, Lundy
    Mike, Berk
    Mona, Patel
    Li Jianbo
    Hooman, Rashidi
    Jesse, McKenney
    Eric, Klein
    Nima, Sharifi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S89 - S89
  • [2] Testosterone Replacement Therapy in Patients with Prostate Cancer After Radical Prostatectomy
    Pastuszak, Alexander W.
    Pearlman, Amy M.
    Lai, Win Shun
    Godoy, Guilherme
    Sathyamoorthy, Kumaran
    Liu, Joceline S.
    Miles, Brian J.
    Lipshultz, Larry I.
    Khera, Mohit
    JOURNAL OF UROLOGY, 2013, 190 (02): : 639 - 644
  • [3] Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
    Porcaro, Antonio Benito
    Panunzio, Andrea
    Bianchi, Alberto
    Cerrato, Clara
    Gallina, Sebastian
    Serafin, Emanuele
    Mazzucato, Giovanni
    Vidiri, Stefano
    D'Aietti, Damiano
    Orlando, Rossella
    Brusa, Davide
    Brunelli, Matteo
    Siracusano, Salvatore
    Pagliarulo, Vincenzo
    Cerruto, Maria Angela
    Tafuri, Alessandro
    Antonelli, Alessandro
    THERAPEUTIC ADVANCES IN UROLOGY, 2023, 15
  • [4] PROSTATE-CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY - RELATION TO AGE
    RIOPEL, MA
    PARTIN, AW
    EPSTEIN, JI
    LABORATORY INVESTIGATION, 1994, 70 (01) : A81 - A81
  • [5] PSA mass as a marker of prostate cancer progression after radical prostatectomy
    Bryniarski, Piotr
    Paradysz, Andrzej
    Fryczkowski, Mieczyslaw
    MEDICAL SCIENCE MONITOR, 2011, 17 (02): : CR104 - CR109
  • [6] NO RECURRENCE OF PROSTATE CANCER AFTER 3 YEARS OF TESTOSTERONE TREATMENT AFTER RADICAL PROSTATECTOMY OF PROSTATE CANCER A CASE REPORT
    Mskhalaya, George
    Kalinchenko, Svetlana
    Tishova, Yuliya
    Saad, Farid
    JOURNAL OF MENS HEALTH, 2010, 7 (03) : 326 - 326
  • [7] Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy
    Weinstein, MH
    Partin, AW
    Veltri, RW
    Epstein, JI
    HUMAN PATHOLOGY, 1996, 27 (07) : 683 - 687
  • [8] Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer
    Dillioglugil, O
    Leibman, BD
    Kattan, MW
    SealeHawkins, C
    Wheeler, TM
    Scardino, PT
    UROLOGY, 1997, 50 (01) : 93 - 99
  • [9] Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy
    Donovan, Michael J.
    Hamann, Stefan
    Clayton, Mark
    Khan, Faisal M.
    Sapir, Marina
    Bayer-Zubek, Valentina
    Fernandez, Gerardo
    Mesa-Tejada, Ricardo
    Teverovskiy, Mikhail
    Reuter, Victor E.
    Scardino, Peter T.
    Cordon-Cardo, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 3923 - 3929
  • [10] Testosterone Replacement Therapy in Patients with High Risk Prostate Cancer After Radical Prostatectomy
    Pastuszak, A.
    Miles, B.
    Khera, M.
    Lipshultz, L.
    UROLOGY, 2012, 80 (03) : S97 - S98